PALMETTO PHARMACEUTICALS, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139
 
  
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 170
 
  
 
B27N MANUFACTURE BY DRY PROCESSES OF ARTICLES, WITH OR WITHOUT ORGANIC BINDING AGENTS, MADE FROM PARTICLES OR FIBRES CONSISTING OF WOOD OR OTHER LIGNOCELLULOSIC OR LIKE ORGANIC MATERIAL 112

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8936635 Bioresorbable nitric oxide agonist prodrug scaffolds for vascular stentsMar 22, 12Jan 20, 15[A61F, A61L]
6465516 Method of stimulating nitric oxide synthaseOct 18, 99Oct 15, 02[A61K]
5968983 Method and formulation for treating vascular diseaseApr 10, 97Oct 19, 99[A01N]
5767160 Method and formulation of stimulating nitric oxide synthesisAug 05, 96Jun 16, 98[A61K]
5543430 Method and formulation of stimulating nitric oxide synthesisOct 05, 94Aug 06, 96[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0094,447 Novel Nitric Oxide Synthase Agonist PolymersAbandonedNov 14, 14Apr 02, 15[A61K, C08G]
2011/0275,649 Combination therapy for the prevention of statin induced diabetesAbandonedMay 03, 11Nov 10, 11[A61K, A61P, B65B]
2011/0212,174 CONTROLLED RELEASE ARGININE FORMULATIONSAbandonedMar 15, 11Sep 01, 11[A61K, A61P]
2011/0196,039 Controlled release arginine formulationsAbandonedJun 28, 01Aug 11, 11[A61K, B27N]
2008/0145,424 Sustained release L-arginine formulations and methods of manufacture and useAbandonedMar 24, 06Jun 19, 08[A61K]
7381731 Pharmaceutical composition comprising citrullineExpiredJan 23, 04Jun 03, 08[A61K]
2006/0029,668 Sustained release L-arginine formulations and methods of manufacture and useAbandonedMay 09, 05Feb 09, 06[A61K]
2005/0287,210 Sustained release L-arginine formulations and methods of manufacture and useAbandonedJan 24, 05Dec 29, 05[A61K]
2005/0288,372 Methods of treating various conditions by administration of sustained released L-ArginineAbandonedJan 24, 05Dec 29, 05[A61K]
2005/0288,373 Methods of treating various conditions by administration of sustained release L-arginineAbandonedApr 14, 05Dec 29, 05[A61K]
2005/0106,269 Increasing cerebral bioavailability of drugsAbandonedSep 28, 04May 19, 05[A61K]
2005/0085,548 Method and formulation for treating vascular diseaseAbandonedAug 05, 04Apr 21, 05[A61K]
2004/0242,682 Compositions comprising arginine and nitratesAbandonedJan 23, 04Dec 02, 04[A61K]
6818669 Increasing cerebral bioavailability of drugsExpiredSep 19, 01Nov 16, 04[A61K]
2004/0204,484 Therapeutic mixture useful in inhibiting lesion formation after vascular injuryAbandonedJul 29, 02Oct 14, 04[A61K]
2003/0114,515 Therapeutic mixture of HMG-COA reductase inhibitorsAbandonedOct 11, 02Jun 19, 03[A61K]
6425881 Therapeutic mixture useful in inhibiting lesion formation after vascular injuryExpiredApr 16, 99Jul 30, 02[A61M]
6239172 Formulations for treating disease and methods of using sameExpiredJan 07, 99May 29, 01[A61K, A01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.